SEC Form 4 · accession 0001013606-18-000084
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher G. Chavez
Director
Period of report
May 29, 2018
Accepted (ET)
May 30, 2018 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 29, 2018 | S | 8 | $5.64 | D | 378,354 | D | |
| Common StockF1 | May 29, 2018 | S | 8 | $5.70 | D | 378,346 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold to cover account administrative fees and were not sold at the discretion, or with the specific authorization, of the Reporting Person.